<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154560">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01712191</url>
  </required_header>
  <id_info>
    <org_study_id>00017</org_study_id>
    <nct_id>NCT01712191</nct_id>
  </id_info>
  <brief_title>Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant</brief_title>
  <official_title>Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Active Implants</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Active Implants</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-center, open label, non-randomized study, evaluating the
      treating of medial meniscus deficiency with the NUsurface Meniscus Implant.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2011</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Knee injury and Osteoarthritis Outcome Score (KOOS)</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Treating the Meniscally Deficient Knee.</condition>
  <arm_group>
    <arm_group_label>NUsurface Meniscus Implant</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NUsurface Meniscus Implant</intervention_name>
    <arm_group_label>NUsurface Meniscus Implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Have a degenerative and/or torn meniscus and/or previous meniscectomy as confirmed by
             diagnostic MRI.

          2. Have a pain score of 75 or less on the KOOS pain scale, with 100 being normal.

          3. Be in neutral alignment +/- 5 degrees of the mechanical axis.

          4. Be between age 35 and 75 at the time of the planned surgery.

          5. Be able to be fitted anatomically with a size 30 to 90 NUsurface® device.

          6. Have a normal mental status.

          7. Be willing and able to attend all follow up visits, complete all study
             questionnaires, and undergo required X-ray and MRI schedule.

          8. Be able and willing to understand and sign the informed consent form.

        Exclusion Criteria:

          1. Have evidence of a Grade IV articular cartilage loss on the medial tibial plateau or
             femoral condyle that could contact the NUsurface implant

          2. Have lateral compartment pain with lateral articular cartilage damage greater than
             Grade II (OB), and/or a lateral meniscus tear(s)

          3. Have a varus or valgus knee deformity &gt; 5 degrees.

          4. Have a laxity level of more than II (ICRS), secondary to previous injury of the
             anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or
             lateral collateral ligament (LCL) and/or medial collateral ligament (MCL).

          5. Have patella instability or non-anatomically positioned patella

          6. Have patellar compartment pain and/or patellar articular cartilage damage greater
             than Grade II (OB).

          7. Need a tibial osteotomy at the time of surgery.

          8. Have an ACL reconstruction performed less than 9 months before implanting the
             NUsurface® device

          9. Have any type of previously implanted prosthetic meniscus or ligament or knee implant
             made of plastic.

         10. Have a knee flexion contracture  &gt; 10 degrees

         11. Be unable to flex the knee to 90 degrees

         12. Have a leg length discrepancy causing a noticeable limp.

         13. Have had a previous major knee condyle surgery

         14. Present with insufficiency fractures or avascular necrosis of the medial compartment.

         15. Have an active infection or tumor.

         16. Have any type of knee joint inflammatory disease including Sjogren's syndrome.

         17. Have neuropathic knee osteoarthropathy, also known as Charcot joint.

         18. Have any medical condition that does not allow arthroscopy at the point of entry to
             the knee.

         19. Be pregnant or is a female intending to become pregnant during the study period.

         20. Be mentally incapacitated.

         21. Be a prisoner.

         22. Be a patient who has economic incentive not to improve (e.g., workman's compensation
             patient)

         23. Be morbidly Obese (BMI &gt; 35).

         24. Is unwilling or unable to have an X-ray, Fluro, or MRI of the affected knee
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AZ Monica</name>
      <address>
        <city>Antwerpen</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sporthopaedicum Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniKlinikum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emek Medical Center</name>
      <address>
        <city>Afula</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Assaf Harofeh Medical Center</name>
      <address>
        <city>Beer Yaakoav</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center- Ichilov</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacro Cuore- Don Calabria Hospital</name>
      <address>
        <city>Negar</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Centre</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska universitetssjukhuset</name>
      <address>
        <city>Göteborg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 18, 2013</lastchanged_date>
  <firstreceived_date>October 18, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NUsurface</keyword>
  <keyword>Meniscus</keyword>
  <keyword>Knee</keyword>
  <keyword>KOOS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
